AURA:NASDAQ, Aura Biosciences, Inc.

AURA stock overview

Aura Biosciences, Inc. (AURA:NASDAQ) closed at $6.87 on November 20, 2026, down 1.58% on the day. The stock trades 27.9% below its 52-week high of $9.54 and 45.2% above its 52-week low of $4.73. Over the past year, it gained 24.9%. Aura Biosciences, Inc. is part of the Health Care sector.

Key figures

Price
$6.87
Day change
-1.58%
Volume
791,133
Average volume
842,681
Market cap
714M+
52-week range
$4.73 – $9.54
50-day average
$6.53
200-day average
$6.82

Price action over the past year

In 252 trading sessions since November 20, 2025, AURA closed higher on 113 days (45%). Its best day was May 4, 2026 (+19.12%) and its worst was July 6, 2026 (-8.40%). The stock moved 10% or more in a single session 6 times.

Recent signals

AURA news

About Aura Biosciences, Inc.

Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity.

Similar stocks

Find more stocks like AURA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.